Wei Shen
-
- Effects and risks of endocrine disrupting chemicals 13
- Reproductive Medicine top 2%
- Sperm and Testicular Function 5
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 17
- MicroRNA in disease regulation 9
-
- Reproductive Biology and Fertility 22
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 12
- Pluripotent Stem Cells Research 10
-
- Genetic and phenotypic traits in livestock 8
- Co-authors
- Wei GeYong ZhaoXifeng ZhangMassimo De FeliciShun‐Feng ChengYanni FengLingjiang MinPaul W. Dyce
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Wei Shen
85 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 126
- Health, Toxicology and Mutagenesis 433
- Reproductive Medicine 261
- Cancer Research 405
- Public Health, Environmental and Occupational Health 446
- Molecular Biology 908
Countries citing papers authored by Wei Shen
This map shows the geographic impact of Wei Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Shen more than expected).
Fields of papers citing papers by Wei Shen
This network shows the impact of papers produced by Wei Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Shen. The network helps show where Wei Shen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 7 | |
| 8 | 2022 | 71 | |
| 9 | 2019 | 41 | |
| 10 | 2019 | 67 | |
| 11 | 2017 | 37 | |
| 12 | 2017 | 21 | |
| 13 | 2017 | 34 | |
| 14 | 2017 | 50 | |
| 15 | 2016 | 96 | |
| 16 | 2016 | 3 | |
| 17 | 2014 | 14 | |
| 18 | 2014 | 5 | |
| 19 | 2014 | 92 | |
| 20 | 2012 | 15 |
About Wei Shen
Wei Shen is a scholar working on Cancer Research, Health, Toxicology and Mutagenesis and Developmental Neuroscience, having authored 87 papers that have together received 2.1k indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (22 papers), Cancer-related molecular mechanisms research (17 papers), Effects and risks of endocrine disrupting chemicals (13 papers), Epigenetics and DNA Methylation (12 papers), Pluripotent Stem Cells Research (10 papers), MicroRNA in disease regulation (9 papers), Genetic and phenotypic traits in livestock (8 papers) and Sperm and Testicular Function (5 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (433 citations), Reproductive Medicine (261 citations) and Cancer Research (405 citations). Wei Shen has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Wei Ge, Yong Zhao, Xifeng Zhang, Massimo De Felici, Shun‐Feng Cheng, Yanni Feng, Lingjiang Min, Paul W. Dyce, Junjie Wang and Lan Li. Their work appears in journals such as Theriogenology, Journal of Pineal Research, Cell Cycle, Gene and Reproduction Fertility and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.